Analysis of willingness to participate in clinical trials using antiviral drugs for HIV prevention among those with HIV-infected regular sexual partners
He Jiatong,Gao Feifei,Zhong Xiaoni,Peng Bin,Zhang Yan,Dai Jianghong,Song Benli,Huang Ailong.Analysis of willingness to participate in clinical trials using antiviral drugs for HIV prevention among those with HIV-infected regular sexual partners[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(02):164-169.
He Jiatong,Gao Feifei,Zhong Xiaoni,Peng Bin,Zhang Yan,Dai Jianghong,Song Benli,Huang Ailong.Analysis of willingness to participate in clinical trials using antiviral drugs for HIV prevention among those with HIV-infected regular sexual partners[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(02):164-169.DOI:
Objective To investigate the willingness and its influencing factors to participate in the clinical trials which take antiviral drugs to prevent HIV among the HIV-negative persons whose regular sexual partners were HIV-infected persons (PARs) in Sichuan and Xinjiang
China. Methods A cross-sectional survey was conducted and influencing factors were analyzed by univariate and multivariate logistic regression. Results Totally 396 qualified subjects were
recruited
of which 12.88% had ever heard and 85.86% were willing to participate in the clinical trials of HIV prevention. Household registration (rural/urban: AOR=4.269
P
=0.000 5)
self-awareness of HIV infection risk (high/low: AOR=2.509
P
=0.022 1; moderate/low: AOR=2.338
P
=0.048 4)
using condoms or not when having sex with HIV-infected partners in the nearly six months (not using/not having sex: AOR=10.451
P
=0.029 4)
and attitude to HIV-infected partners to medication (support/not support or unsure: AOR=2.079
P
=0.042 9) were screened by multivariate analysis. Conclusion The willingness is relatively high